Resuscitation
Volume 81, Issue 5 , Pages 591-595 , May 2010

Ischaemia-modified albumin predicts the outcome of cardiopulmonary resuscitation: An experimental study

  • Theodoros Xanthos

      Affiliations

    • Department of Experimental Surgery and Surgical Research, University of Athens, Medical School, 15B Agiou Thoma Street, 11527 Athens, Greece
    • Corresponding Author InformationCorresponding author at: Tel.: +30 2107462500; fax: +30 2107462500.
    • ,
  • Nicoletta Iacovidou

      Affiliations

    • Neonatal Division, 2nd Department of Obstetrics and Gynecology, Athens University Medical School, 10682 Athens, Greece
    • ,
  • Ioannis Pantazopoulos

      Affiliations

    • Department of Experimental Surgery and Surgical Research, University of Athens, Medical School, 15B Agiou Thoma Street, 11527 Athens, Greece
    • ,
  • Ioannis Vlachos

      Affiliations

    • Department of Experimental Surgery and Surgical Research, University of Athens, Medical School, 15B Agiou Thoma Street, 11527 Athens, Greece
    • ,
  • Eleni Bassiakou

      Affiliations

    • Department of Experimental Surgery and Surgical Research, University of Athens, Medical School, 15B Agiou Thoma Street, 11527 Athens, Greece
    • ,
  • Konstantinos Stroumpoulis

      Affiliations

    • Department of Experimental Surgery and Surgical Research, University of Athens, Medical School, 15B Agiou Thoma Street, 11527 Athens, Greece
    • ,
  • Evagelia Kouskouni

      Affiliations

    • Department of Biopathology, University of Athens, Aretaieion Hospital, Athens, Greece
    • ,
  • Andreas Karabinis

      Affiliations

    • Department of Intensive Care, General State Hospital of Athens, Greece
    • ,
  • Lila Papadimitriou

      Affiliations

    • Department of Experimental Surgery and Surgical Research, University of Athens, Medical School, 15B Agiou Thoma Street, 11527 Athens, Greece

Received 4 November 2009 ,Revised 18 January 2010 ,Accepted 20 January 2010.

References 

  1. Pantazopoulos I, Papadimitriou L, Dontas I, Demestiha T, Iakovidou N, Xanthos T. Ischaemia modified albumin in the diagnosis of acute coronary syndromes. Resuscitation. 2009;80:306–310
  2. Worster A, Devereaux PJ, Heels-Ansdell D, et al. Capability of ischemia modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ. 2005;172:1685–1690
  3. Koudouna E, Xanthos T, Bassiakou E, et al. Levosimendan improves the initial outcome of cardiopulmonary resuscitation in a swine model of cardiac arrest. Acta Anaesthesiol Scand. 2007;51:1123–1129
  4. Roy D, Quilesa J, Aldamaa G, et al. Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol. 2004;97:297–301
  5. Bar-Or D, Curtis G, Rao N, Bampos N, Lau E. Characterization of the Co(2q) and Ni(2q) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur J Biochem. 2001;268:42–47
  6. Xanthos T, Lelovas P, Vlachos I, et al. Cardiopulmonary arrest and resuscitation in Landrace/Large White swine: a research model. Lab Anim. 2007;41:353–362
  7. van Alem AP, Vrenken RH, de Vos R, Tijssen JG, Koster RW. Use of automated external defibrillator by first responders in out-of-hospital cardiac arrest: prospective controlled trial. BMJ. 2003;327:1312–1317
  8. Iacovidou N, Briana DD, Boutsikou M, et al. Cord blood ischemia-modified albumin levels in normal and intrauterine growth restricted pregnancies. Mediat Inflamm. 2008;2008:523081
  9. Hoffman JI. Maximal coronary flow and the concept of coronary vascular reserve. Circulation. 1984;70:153–159
  10. Klocke FJ, Ellis AK. Control of coronary blood flow. Annu Rev Med. 1980;31:489–508
  11. Ditchey RV, Lindenfeld J. Failure of epinephrine to improve the balance between myocardial oxygen supply and demand during closed-chest resuscitation in dogs. Circulation. 1988;78:382–389
  12. Luqman N, Sung RJ, Wang CL, Kuo CT. Myocardial ischemia and ventricular fibrillation: pathophysiology and clinical implications. Int J Cardiol. 2007;119:283–290
  13. Morrow DA, De Lemos JA, Sabatine MS, Antman EM. The search for a biomarker of cardiac ischemia. Clin Chem. 2003;49:537–539
  14. Anwaruddin S, Januzzi JL, Baggish AL, Lewandrowski EL, Lewandrowski KB. Ischemia modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting. Am J Clin Pathol. 2005;123:140–145
  15. Sanders AB, Ogle M, Ewy GA. Coronary perfusion pressure during cardiopulmonary resuscitation. Am J Emerg Med. 1985;3:11–14
  16. Ralston SH, Voorhees WD, Babbs CF. Intrapulmonary epinephrine during prolonged cardiopulmonary resuscitation: improved regional blood flow and resuscitation in dogs. Ann Emerg Med. 1984;13:79–86
  17. Michael JR, Guerci AD, Koehler RC, et al. Mechanism by which epinephrine augments cerebral and myocardial perfusion during cardiopulmonary resuscitation in dogs. Circulation. 1984;69:822–835
  18. Neimann JT, Rosborough JP, Niskanen RA, Alferness C, Criley JM. Mechanical “cough” cardiopulmonary resuscitation during cardiac arrest in dogs. Am J Cardiol. 1985;55:199–204
  19. Feneley MP, Maier GW, Kern KB, et al. Influence of compression rate on initial success of resuscitation and 24-hour survival after prolonged manual cardiopulmonary resuscitation in dogs. Circulation. 1988;77:240–250
  20. Kern KB, Sanders AB, Badylak SF, et al. Long-term survival with open-chest cardiac massage after ineffective closed-chest compressions in a canine model. Circulation. 1987;75:498–503
  21. Roy D, Quiles J, Sinha M, Aldama G, Gaze D, Kaski JC. Effect of direct-current cardioversion on ischemia-modified albumin levels in patients with atrial fibrillation. Am J Cardiol. 2004;93:366–368
  22. Turedi S, Gunduz A, Mentese A, et al. Investigation of the possibility of using ischemia-modified albumin as a novel and early prognostic marker in cardiac arrest patients after cardiopulmonary resuscitation. Resuscitation. 2009;80:994–999
  23. Kumar A, Sivakanesan R, Gunasekera S. Ischemia modified albumin: a potent marker in acute myocardial infarction in normolipidaemic. Pak J Med Sci. 2008;24:364–367
  24. Carreiro-Lewandowski E. Update on cardiac biomarkers. Lab Med. 2006;37:598–605
  25. Apple FS, Wu AH, Mair J, et al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem. 2005;51:810–824
  26. Lippi G, Montagnana M, Salvagno GL, Guidi GC. The measurement of ischemia modified albumin in clinical laboratories: where do we stand?. J Clin Ligand Assay. 2005;28:207–215
  27. Predki PF, Harford C, Brar P, Sarkar B. Further characterization of the N-terminal copper(II)- and nickel(II)-binding motif of proteins. Studies of metal binding to chicken serum albumin and the native sequence peptide. Biochem J. 1992;287:211–215
  28. Gunduz A, Turkmen S, Turedi S, et al. Time-dependent variations in ischemia-modified albumin levels in mesenteric ischemia. Acad Emerg Med. 2009;16:539–543
  29. Apple FS, Quist HE, Otto AP, Mathews WE, Murakami MM. Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race. Clin Chem. 2002;48:1097–1100
  30. Bar-Or D, Rael LT, Bar-Or R, et al. The cobalt-albumin binding assay: insights into its mode of action. Clin Chim Acta. 2008;387:120–127

☆ “A Spanish translated version of the summary of this article appears as Appendix in the final online version at doi:10.1016/j.resuscitation.2010.01.010”.

PII: S0300-9572(10)00052-3

doi: 10.1016/j.resuscitation.2010.01.010

Resuscitation
Volume 81, Issue 5 , Pages 591-595 , May 2010

Article Tools

* Image Usage & Resolution